Original Research
Accepted on 20 May 2024
Exploring MAP2K3 as a Prognostic Biomarker and Potential Immunotherapy Target in Glioma Treatment
in Neuro-Oncology and Neurosurgical Oncology
Original Research
Accepted on 20 May 2024
in Neuro-Oncology and Neurosurgical Oncology
Original Research
Published on 15 May 2024
in Neuro-Oncology and Neurosurgical Oncology
Review
Published on 15 May 2024
in Neuro-Oncology and Neurosurgical Oncology
Case Report
Accepted on 09 May 2024
in Neuro-Oncology and Neurosurgical Oncology
Case Report
Published on 09 May 2024
in Neuro-Oncology and Neurosurgical Oncology
Original Research
Accepted on 30 Apr 2024
in Neuro-Oncology and Neurosurgical Oncology
Original Research
Published on 29 Apr 2024
in Neuro-Oncology and Neurosurgical Oncology
Systematic Review
Published on 26 Apr 2024
in Neuro-Oncology and Neurosurgical Oncology
Original Research
Published on 08 Apr 2024
in Neuro-Oncology and Neurosurgical Oncology
Review
Published on 08 Apr 2024
in Neuro-Oncology and Neurosurgical Oncology
Original Research
Published on 08 Apr 2024
in Neuro-Oncology and Neurosurgical Oncology
Original Research
Published on 04 Apr 2024
in Neuro-Oncology and Neurosurgical Oncology
Case Report
Published on 28 Mar 2024
in Neuro-Oncology and Neurosurgical Oncology
Original Research
Published on 27 Mar 2024
in Neuro-Oncology and Neurosurgical Oncology
Original Research
Published on 15 Mar 2024
in Neuro-Oncology and Neurosurgical Oncology
Editorial
Published on 08 Mar 2024
in Neuro-Oncology and Neurosurgical Oncology